Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01519219 · ClinicalTrials.gov registry record

Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation

A clinical trial, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
208
Enrollment target

NCT01519219 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 208 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01519219 has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
208 participants
Enrollment target

Study Summary

The goal of the trial is to assess the effect of radiation treatment on liver function as determined by indocyanine green extraction. The long term goal is to determine if individual assessment of liver function using the IC-Green method, either alone or in combination with other factors, will provide Radiation Induced Liver Disease (RILD) risk-estimates that are superior to the probabilistic method currently in use.

Interventions

  • RADIATION Hepatic Irradiation

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2004-11-24
Est. Completion 2020-02-19

What the Registry Record Tells You About NCT01519219

The ClinicalTrials.gov registry entry for NCT01519219 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hepatic Irradiation is the first listed.

NCT01519219 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01519219 about?

NCT01519219 is a clinical study titled "Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation". The goal of the trial is to assess the effect of radiation treatment on liver function as determined by indocyanine green extraction. The long term goal is to determine if individual assessment of liver function using the IC-Green method, either alone or in combination with other factors, will provi...

What is the current status of trial NCT01519219?

This trial is currently completed. The enrollment target is 208 participants. The study started on 2004-11-24. Estimated completion is 2020-02-19.

What interventions are being tested in trial NCT01519219?

The interventions under investigation include: Hepatic Irradiation (RADIATION).

Who is sponsoring clinical trial NCT01519219?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.